Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 13, 2013, Pages 1744-1747

  Anuar, A S Saiful ^a   Yusof, M Y Mohd ^a   Tay, S T ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Ciprofloxacin; Gyrase A; Klebsiella pneumoniae; Plasmid mediated qnr determinants

Indexed keywords

ASPARTIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GLYCINE; ISOLEUCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TYROSINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; QNR PROTEIN, KLEBSIELLA PNEUMONIAE;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; GENE AMPLIFICATION; GYRA GENE; KLEBSIELLA PNEUMONIAE; MALAYSIA; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PREVALENCE; QNR GENE; QNRA GENE; QNRB GENE; QNRB1 GENE; QNRB10 GENE; QNRB6 GENE; QNRS GENE; QNRS1 GENE; SEQUENCE ANALYSIS; UNIVERSITY HOSPITAL; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECT; GENETICS; HUMAN; KLEBSIELLA INFECTION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; CROSS INFECTION; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; HOSPITALS, TEACHING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALAYSIA; PLASMIDS; POLYMERASE CHAIN REACTION;

EID: 84884189886     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. STRAHILEVITZ J, JACOBY GA, HOOPER DC, ROBICSEK A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microb Rev 2009; 22: 664-689.
2. DEGUCHI T, FUKUOKA A, YASUDA M, NAKANO M, OZEKI S, KANEMATSU E, NISHINO Y, ISHIHARA S, BAN Y, KAWADA Y. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumonia. Antimicrob Agents Chemother 1997; 41: 699-701.
3. JACOBY GA. Mechanisms of resistance to quinolones. Clin Infect Dis 2005; 41(Suppl) S120-126
4. WANG M, CAO B, YU Q, LIU L, GAO Q, WANG L, FENG L. Analysis of the 16S-23S rRNA gene internal transcribed spacer region in Klebsiella Species. J Clin Microb 2008; 46: 3555-3563.
5. CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI). Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Wayne, PA. 2009; pp. M100-S19.
6. CATTOIR V, POIREL L, ROTIMI V, SOUSSY C, NORDMANN P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacter ial isolates. J Antimicrob Chemother 2007; 60: 394-397.
7. LING JM, CHAN EW, LAM AW, CHENG AF. Alterations in topoisomerase genes of fluoroquinolone-resistant Salmonella in Hong Kong. Antimicrob Agents Chemother 2003; 47: 3567-3575.
8. LASCOLS C, ROBERT J, CATTOIR V, BEBEAR C, CAVALLO JD, PODGLAJEN I, PLOY MC, BONNET R, SOUSSY CJ, CAMBAU E. Type II topoisomerase alterations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. Int J Antimicrob Agents 2007; 29: 402-409.
9. CHENIA HY, PILLAY B, PILLAY D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J Antimicrob Chemother 2006; 58: 1274-1278.
10. MARTÍNEZ-MARTÍNEZ L, PASCUAL A, CONEJO MDEL C, GARCÍA I, JOYANES P, DOMÉNECH-SÁNCHEZ A, BENEDÍ VJ. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extendedspectrum ?-lactamase production. Antimicrob Agents Chemother 2002; 46: 3926-3932.
11. YOSHIDA H, BOGAKI M, NAKAMURA M, NAKAMURA S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990; 34: 1271-1272.
12. FU Y, GUO L, XU Y, ZHANG W, GU J, XU J, CHEN X, ZHAO Y, MA J, LIU X, ZHANG F. Alteration of GyrA amino acid required for ciprofloxacin resistance in Klebsiella pneumoniae isolates in China. Antimicrob Agents Chemother 2008; 52: 2980-2983.
13. SCHNEIDERS T, AMYES SG, LEVY SB. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 2003; 47: 2831-2837.
14. GENSBERG K, JIN YF, PIDDOCK LJV. A novel gyrB alteration in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium. FEMS Microb Lettt 1995; 132: 57-60.
15. WEIGEL LM, ANDERSON GJ, TENOVER FC. DNA gyrase and topoisomerase IV alterations associated with fluoroquinolone resistance in Proteus mirabilis. Antimicrob Agents Chemother 2002; 46: 2582-2587.